Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015655:1-Methyl-4-phenylpyridinium; D000328:Adult; D000818:Animals; D001921:Brain / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D005609:Free Radicals; D006801:Humans; D008297:Male; D008543:Melanins / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000201:enzymology; D011725:Pyridines / Q000009:adverse effects*; D011726:Pyridinium Compounds / Q000009:adverse effects / Q000378:metabolism
D005609:Free Radicals; D008543:Melanins; D011725:Pyridines; D011726:Pyridinium Compounds; C014121:neuromelanin; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008995:Monoamine Oxidase; D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine; D009638:Norepinephrine